The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,601–11,700 of 31,469
Jung, K. Y., Kim, K. M., Ku, E. J., Kim, Y. J., Lee, D.-H., Choi, S. H., Jang, H. C., Shin, C. S., Park, K. S., & Lim, S. K. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3315-7 · Cited by 30
Saravia, G., Civeira, F., Hurtado-Roca, Y., Andres, E. M., León, M., Pocoví, M., Ordovás, J. M., Güallar, E., Fernández‐Ortíz, A., Casasnovas, J. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132244 · Cited by 35
Qu, Z., Zhu, Y., Jiang, J., Shi, Y., & Chen, Z. (2013) · Europe PMC (PubMed Central) · Cited by 34
Kim, H. ‐., Park, M.-J., & Han, J.-S. (2011) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2011.40.5.696 · Cited by 30
Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon
Jao, J. K., Kirmse, B., Yu, C., Qiu, Y., Powis, K. M., Nshom, E. M., Epie, F., Tih, P. M., SPERLING, R. S., Abrams, E. J., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2198 · Cited by 31
Síndrome metabólica, resistência à ação da insulina e doença cardiovascular no diabete melito tipo 1
Rodrigues, T. D. C., Canani, L. H. S., & Gross, J. L. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010000100020 · Cited by 30
Been, L. F., Hatfield, J., Shankar, A., Aston, C. E., Ralhan, S. K., Wander, G. S., Mehra, N. K., Singh, J. R., Mulvihill, J. J., & Sanghera, D. K. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.01.006 · Cited by 30
Becer, E., Mehmetçik, G., Bareke, H., et al. (2013) · Gene · doi:10.1016/j.gene.2013.08.003 · Cited by 30
Boufassa, F., Goujard, C., Viard, J., Carlier, R., Lefebvre, B., Yéni, P., Bouchaud, O., Capeau, J., Meyer, L., Vigouroux, C., et al. (2011) · Antiviral Therapy · doi:10.3851/imp1916 · Cited by 30
Serum uric acid level is associated with the development of microalbuminuria in Korean men
Oh, C., Park, S. K., & Ryoo, J. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12180 · Cited by 30
Kopp, H.-P., Krzyżanowska, K., Schernthaner, G.-H., Kriwanek, S., & Schernthaner, G. (2006) · Obesity Surgery · doi:10.1381/096089206778392130 · Cited by 30
Okuno, M., Kim, M., Mizu, M., Mori, M., Mori, H., & Yamori, Y. (2010) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637481003694576 · Cited by 30
Plasma Procalcitonin Is an Independent Predictor of Graft Failure Late After Renal Transplantation
van Ree, R. M., de Vries, A. P. J., Oterdoom, L. H., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181ac9ea0 · Cited by 30
Panagiotopoulos, C., Ronsley, R. J., Al-Dubayee, M., Brant, R., Kuzeljevic, B., Rurak, E., Cristall, A., Marks, G. N., Sneddon, P., Hinchliffe, M., et al. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8124662 · Cited by 30
Plasma Visfatin Is Increased after High-Intensity Exercise
Ghanbari–Niaki, A., Saghebjoo, M., Soltani, R., & Kirwan, J. P. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000313936 · Cited by 30
Nikooie, R., Rajabi, H., Reza, G., Atabi, F., Omidfar, K., Aveseh, M., & Larijani, B. A. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0263-6 · Cited by 31
Pescatello, L. S., Devaney, J. M., Hubal, M. J., Thompson, P. D., & Hoffman, E. P. (2013) · BioMed Research International · doi:10.1155/2013/643575 · Cited by 30
Thierer, J. M., Acosta, A., Vainstein, N. E., Sultan, M., Francesia, A. N., Marino, J. C., Prado, A. H., Guglielmone, R., Trivi, M., Boero, L. E., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.017 · Cited by 30
Diet but not aerobic exercise training reduces skeletal muscle TNF-a in overweight humans
Nestel, P. J., Taylor, A. J., Drew, B. G., Kingwell, B. A., & Ferrier, K. E. (2004) · Diabetologia · doi:10.1007/s00125-004-1373-z · Cited by 31
Valcour, V., Maki, P. M., Bacchetti, P., Anastos, K., Crystal, H., Young, M., Mack, W. J., Cohen, M. H., Golub, E. T., & Tien, P. C. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0159 · Cited by 30
Evolution of OGTT in patients with β-thalassaemia major in relation to chelation therapy
Christoforidis, A., Perifanis, V., Tsatra, I., Vlachaki, E., & Athanassiou‐Metaxa, M. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.010 · Cited by 30
Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., et al. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743005 · Cited by 30
Wongwananuruk, T., Rattanachaiyanont, M., Indhavivadhana, S., Leerasiri, P., Techatraisak, K., Tanmahasamut, P., Angsuwathana, S., & Dangrat, C. (2012) · International Journal of Endocrinology · doi:10.1155/2012/529184 · Cited by 30
Burrows, R. A., Leiva, L., Gerardo Weisstaub, N., Lydia Lera, M., Cecilia Albala, B., Blanco, E., & Gahagan, S. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00685.x · Cited by 31
Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults
Lee, S., Ko, B.-J., Gong, Y.-H., Han, K., Lee, A. S. Y., Han, B., Yoon, Y. J., Park, S.-Y., Kim, J., & Mantzoros, C. S. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0851-z · Cited by 30
Novel melanocortin 4 receptor gene mutations in severely obese children
Lee, Y. S., Poh, L. K. S., Kek, B. L. K., & Loke, K. Y. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03071.x · Cited by 30
Raloxifene slows down the progression of intima-media thickness in postmenopausal women
Colacurci, N., Fornaro, F., Cobellis, L., et al. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3180577893 · Cited by 30
García-Sánchez, C., Torres‐Tamayo, M., Juárez-Meavepeña, M., López-Osorio, C., Toledo-Ibelles, P., Monter-Garrido, M., Cruz‐Robles, D., Carreón‐Torres, E., Vargas‐Alarcón, G., & Pérez-Méndez, O. A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.10.021 · Cited by 30
Derosa, G., Cicero, A. F. G., Gaddi, A. V., Mugellini, A., Ciccarelli, L., & Fogari, R. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000161403.91456.39 · Cited by 28
Pescatello, L. S., Blanchard, B. E., Heest, J. L. V., Maresh, C. M., Gordish‐Dressman, H., & Thompson, P. D. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-12 · Cited by 30
Brain-derived neurotrophic factor expression ex vivo in obesity
Huang, C., Mari, D. C., WHITEHURST, M. A., Slusher, A. L., Wilson, A., & Shibata, Y. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.10.004 · Cited by 30
Study of adiponectin in chronic liver disease and cholestasis
Salman, T., Allam, N. A. A., El-Azab, G., Shaarawy, A., Hassouna, M. M., & El-haddad, O. M. (2010) · Hepatology International · doi:10.1007/s12072-010-9216-0 · Cited by 30
Scherag, A., Kleber, M., Boes, T., Kolbe, A., Ruth, A., Grallert, H., Illig, T., Heid, I. M., Toschke, A. M., Grau, K., et al. (2011) · Obesity · doi:10.1038/oby.2011.339 · Cited by 30
Cardiometabolic Risk in Chinese Women with Prior Gestational Diabetes: A 15-Year Follow-Up Study
Tam, W. H., Ronald, C. W., Yang, X., Ko, G. T.-C., Lao, T. T.-H., Chan, M. H. M., Lam, C. W.-K., Cockram, C. S., & Chan, J. C. N. (2011) · Gynecologic and Obstetric Investigation · doi:10.1159/000329339 · Cited by 29
Insulin resistance in chronic hepatitis C
Bernsmeier, C., & Heim, M. H. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12765 · Cited by 30
Shin, J. A., Mo, E. Y., Kim, E. S., Moon, S. D., & Han, J. H. (2014) · International Journal of Endocrinology · doi:10.1155/2014/104318 · Cited by 30
Corte, C. D., Fintini, D., Giordano, U., Cappa, M., Brufani, C., Majo, F., Mennini, C., & Nobili, V. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04498.x · Cited by 30
Dias, J. P., & Couture, R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01521.x · Cited by 30
Ando, H., Sugimoto, K., Yanagihara, H., Tsuruoka, S., Saito, T., Takamura, T., Kaneko, S., & Fujimura, A. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04945.x · Cited by 30
Campos-Shimada, L. B., Gilglioni, E. H., Garcia, R. F., Brito, M. D. N., Natali, M. R. M., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.043 · Cited by 30
Vielwerth, S., Jensen, R. B., Larsen, T., Holst, K. K., Mølgaard, C., Greisen, G. O., & Vaag, A. A. (2008) · Diabetologia · doi:10.1007/s00125-008-1037-5 · Cited by 30
Graham, U. M., McCance, D. R., Young, I. S., & Mullan, K. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.89 · Cited by 30
Ando, H., Ushijima, K., Kumazaki, M., Eto, T., Takamura, T., Irie, S., Kaneko, S., & Fujimura, A. (2010) · Chronobiology International · doi:10.3109/07420520903398617 · Cited by 30
Færch, K., Højlund, K., Vind, B. F., Vaag, A. A., Dalgård, C., Nielsen, F., & Grandjean, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1342 · Cited by 30
Masaki, T., Anan, F., Shimomura, T., Fujiki, M., Saikawa, T., & Yoshimatsu, H. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.016 · Cited by 30
Auriemma, R. S., Pivonello, R., Galdiero, M., Martino, M. C. D., Leo, M. D., Vitale, G., Lombardi, G., & Colao, A. A. L. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345632 · Cited by 29
Nakhjavani, M., Morteza, A., Asgarani, F., Khalilzadeh, O., Ghazizadeh, Z., Bathaie, S. Z., & Esteghamati, A. (2012) · Gene · doi:10.1016/j.gene.2012.01.085 · Cited by 30
Olsen, N. J., Andersen, L. B., Wedderkopp, N., Kristensen, P. L., & Heitmann, B. L. (2012) · Obesity Facts · doi:10.1159/000341631 · Cited by 30
Μanios, Y., Kourlaba, G., Grammatikaki, E., Koubitski, A., Siatitsa, P.-E., Vandorou, A., Kyriakou, K., Dede, V., & Moschonis, G. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.172 · Cited by 30
Aramă, V., Tilişcan, C., Streinu‐Cercel, A., Ion, D. A., Mihăilescu, R., Munteanu, D., Hristea, A., Aramă, Ș. S., & the SLD-ART study group (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-4 · Cited by 30
Larrieta‐Carrasco, E., Acuña-Alonzo, V., Velázquez‐Cruz, R., Barquera, R., León‐Mimila, P., Villamil‐Ramírez, H., Menjívar, M., Romero‐Hidalgo, S., Méndez‐Sánchez, N., Cárdenas, V., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3341-0 · Cited by 31
Ruchat, S.-M., Elks, C. E., Loos, R. J. F., Vohl, M., Weisnagel, S. J., Rankinen, T., Bouchard, C., & Përusse, L. (2009) · Lifestyle Genomics · doi:10.1159/000259341 · Cited by 30
Song, Y., Huang, Y., Song, Y., Hevener, A. L., Ryckman, K. K., Qi, L., LeBlanc, E. S., Kazlauskaite, R., Brennan, K. M., & Liu, S. (2015) · Diabetologia · doi:10.1007/s00125-014-3479-2 · Cited by 30
Mohn, A., Marcovecchio, M. L., de Giorgis, T., Pfaeffle, R. W., Chiarelli, F., & Kiess, W. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324957 · Cited by 30
Howard, A. A., Lo, Y., Floris-Moore, M., Klein, R. S., Fleischer, N., & Schoenbaum, E. E. (2007) · AIDS · doi:10.1097/qad.0b013e3280464db7 · Cited by 30
Michaliszyn, S. F., Soreca, I., Otto, A. D., Jakicic, J. M., & Fagiolini, A. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1207 · Cited by 30
Hileman, C. O., Carman, T. L., Storer, N. J., Labbato, D. E., White, C. A., & McComsey, G. A. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0088 · Cited by 30
Yang, M., Dong, J., Liu, H., Li, L., & Yang, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026359 · Cited by 30
Chang, C. H., McNamara, L. A., Wu, M. S., Muise, E. S., Tan, Y., Wood, H. B., Meinke, P. T., Thompson, J. R., Doebber, T. W., Berger, J. P., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.036 · Cited by 31
Webster, R. J., Warrington, N. M., Weedon, M. N., Hattersley, A. T., McCaskie, P. A., Beilby, J. P., Palmer, L. J., & Frayling, T. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1175-9 · Cited by 30
Zheng, J., Xiao, X., Zhang, Q., Yu, M., Xu, J., & Wang, Z. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12303 · Cited by 30
Kawakita, R., Hosokawa, Y., Fujimaru, R., Tamagawa, N., Urakami, T., Takasawa, K., Moriya, K., Mizuno, H., Maruo, Y., Takuwa, M., et al. (2014) · Diabetic Medicine · doi:10.1111/dme.12487 · Cited by 30
Winkler, C., Marienfeld, S., Zwilling, M., Bonifacio, E. E., & Ziegler, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1461-1 · Cited by 31
Stöwhas, A.-C., Latshang, T. D., Cascio, C. M. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070081 · Cited by 30
Algorithm for Complementary and Alternative Medicine Practice and Research in Type 2 Diabetes
Bradley, R. D., Oberg, E. B., Calabrese, C., & Standish, L. J. (2007) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.6207 · Cited by 30
Shadoan, M., Anthony, M., Rankin, S. E., Clarkson, T. B., & Wagner, J. (2003) · Metabolism: Clinical and Experimental · doi:10.1016/s0026-0495(03)00181-1 · Cited by 34
Fenretinide Ameliorates Insulin Resistance and Fatty Liver in Obese Mice
Koh, I.-U., Jun, H.-S., Choi, J. S., Lim, J. H., Kim, W., Yoon, J. B., & Song, J. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.369 · Cited by 31
Žák, A., TVRZICKÁ, E., Vecka, M., Jáchymová, M., Duffková, L., Staňková, B., Vávřová, L., Kodydková, J., & Zeman, M. (2007) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.212.359 · Cited by 30
Petta, S., Tripodo, C., Grimaudo, S., Cabibi, D., Cammà, C., Cristina, A. D., Marco, V. D., Vita, G. D., Ingrao, S., Mazzola, A., et al. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.12.013 · Cited by 30
Mamo, J., James, A. P., Soares, M. J., Griffiths, D., Purcell, K., & Schwenke, J. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602224 · Cited by 27
Kring, S. I. I., Brummett, B. H., Barefoot, J. C., Garrett, M. E., Ashley‐Koch, A. E., Boyle, S. H., Siegler, I. C., Sørensen, T. I. A., & Williams, R. B. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181de30ad · Cited by 34
Glucose Regulation and Cognitive Function after Bariatric Surgery
Galioto, R., Alosco, M., Spitznagel, M., Strain, G., Devlin, M., Cohen, R., Crosby, R., Mitchell, J., & Gunstad, J. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1023264 · Cited by 28
Clinical Measures of Islet Function: Usefulness to Characterize Defects in Diabetes
Åhrén, B., Pratley, R. E., Soubt, M., Dunning, B. E., & Foley, J. E. (2008) · Current Diabetes Reviews · doi:10.2174/157339908784220714 · Cited by 30
Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes
Bach‐Ngohou, K., Ouguerram, K., Nazih, H., Maugère, P., Piquer, B. R., Zaïr, Y., Frénais, R., Krempf, M., & Bard, J. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802149 · Cited by 30
Pighon, A., Paquette, A., Barsalani, R., et al. (2008) · Climacteric · doi:10.1080/13697130802447074 · Cited by 30
Abdullah, A., Hasan, H. A., Raigangar, V. L., & Bani‐Issa, W. (2012) · International Journal of Endocrinology · doi:10.1155/2012/420792 · Cited by 30
Chen, H., An, R., Hu, S., Wei-lin, M., Xin, X., & Jia, W. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.001 · Cited by 30
Alberga, A. S., Frappier, A., Sigal, R. J., Prud’homme, D., & Kenny, G. P. (2013) · The Physician and Sportsmedicine · doi:10.3810/psm.2013.05.2014 · Cited by 31
Insulin resistance in women with hirsutism
Cebeci, F., Onsun, N., & Mert, M. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.28563 · Cited by 30
Langkilde, A., Petersen, J., Henriksen, J. H., Jensen, F. K., Gerstoft, J., Eugen‐Olsen, J., & Andersen, O. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0036-x · Cited by 29
Tushuizen, M. E., Pouwels, P. J. W., Bontemps, S., Rustemeijer, C., Matikainen, N., Heine, R. J., Taskinen, M., & Diamant, M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.002 · Cited by 30
Mori, H., Okada, Y., Arao, T., et al. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0032-x · Cited by 30
Simón, E., Macarulla, M. T., Churruca, I., Fernández‐Quintela, A., & Portillo, M. P. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.06.001 · Cited by 30
Shea, J. L., Randell, E. W., Vasdev, S., Wang, P., Roebothan, B., & Sun, G. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1310 · Cited by 30
Pulse Wave Velocity in Familial Combined Hyperlipidemia
TERAVEST, E., Holewijn, S., Bredie, S. J. H., VANTITS, L., Stalenhoef, A. F. H., & DEGRAAF, J. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.09.015 · Cited by 30
Retnakaran, R. R., Qi, Y., Opsteen, C., Vivero, E. J. A. R., & Zinman, B. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01254.x · Cited by 30
Clark, K., James, A. P., & Mamo, J. C. L. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-9 · Cited by 30
Golpaie, A., Tajik, N., Masoudkabir, F., Karbaschian, Z., Talebpour, M., Hoseini, M., & Hosseinzadeh‐Attar, M. J. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0295 · Cited by 30
Tsuzaki, K., Kotani, K., Sano, Y., Fujiwara, S., Takahashi, K., & Sakane, N. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-150 · Cited by 31
Somani, R., Grant, P. J., Kain, K., Catto, A. J., & Carter, A. M. (2006) · Stroke · doi:10.1161/01.str.0000231649.56080.6d · Cited by 30
McMurray, R. G., Hosick, P. A., & Bugge, A. (2011) · Annals of Human Biology · doi:10.3109/03014460.2011.598561 · Cited by 30
Wang, C., Hu, C., Zhang, R., Bao, Y., Ma, X., Lu, J., Qin, W., Shao, X., Lu, J., Xu, J., et al. (2009) · Diabetes · doi:10.2337/db08-1064 · Cited by 30
Baş, A. L., Demirci, S., Yazıhan, N., Üney, K., & Kaya, E. E. (2012) · International Journal of Endocrinology · doi:10.1155/2012/947187 · Cited by 31
Guaraldi, G., Lonardo, A., Ballestri, S., et al. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.12.009 · Cited by 30
Gueugnon, C., Mougin, F., Simon-Rigaud, M.-L., Regnard, J., Nègre, V., & Dumoulin, G. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h2012-045 · Cited by 30
Ben, M. D., Polimeni, L., Brancorsini, M., Costanzo, A. D., D’Erasmo, L., Baratta, F., Loffredo, L., Pastori, D., Pignatelli, P., Violi, F., et al. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.05.012 · Cited by 30
Serum 1,5‐anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes
Kim, W.-J., Park, C. Y., Park, S. E., Rhee, E., Lee, W., Oh, K.-W., Park, S. W., Kim, S. W., Park, H. S., Kim, Y. J., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03613.x · Cited by 31
Jung, C., Kim, B., Kim, K.-J., Jung, S.-H., Kim, C., Kang, S., & Mok, J. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-67 · Cited by 30
Yan, Y., North, K. E., Ballantyne, C. M., Brancati, F. L., Chambless, L. E., Franceschini, N., HEISS, G. M., Köttgen, A., Pankow, J. S., Selvin, E., et al. (2008) · Diabetes · doi:10.2337/db08-0569 · Cited by 30
Thorsby, P. M., Midthjell, K., Gjerlaugsen, N., Holmen, J., Hanssen, K. F., Birkeland, K. I., & Berg, J. P. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802538188 · Cited by 31
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
